Feig DI, Kang D, Johnson RJ: Uric acid and cardiovascular risk. N Engl J Med. 2008, 359: 1811-1821. 10.1056/NEJMra0800885.
Article
CAS
PubMed
PubMed Central
Google Scholar
Chien KL, Chen MF, Hsu HC, Chang WT, Su TC, Lee YT, Hu FB: Plasma uric acid and risk of type 2 diabetes in Chinese community. Clin Chem. 2008, 54 (2): 310-316. 10.1373/clinchem.2007.095190.
Article
CAS
PubMed
Google Scholar
Holme I, Aastveit AH, Hammar N, Jungner I, Walldius G: Uric acid and risk of myocardial infarction, stroke and congestive heart failure in 417,734 men and women in the apolipoprotein MOrtality RISk study (AMORIS). J Intern Med. 2009, 266 (6): 558-570. 10.1111/j.1365-2796.2009.02133.x.
Article
CAS
PubMed
Google Scholar
Bos MJ, Koudstaal PJ, Hofman A, Witteman JCM, Bretler MMB: Uric acid is a risk factor for myocardial infarction and stroke: the Rotterdam study. Stroke. 2006, 37: 1503-1507. 10.1161/01.STR.0000221716.55088.d4.
Article
CAS
PubMed
Google Scholar
Klein BE, Klein R, Lee KE: Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in beaver Dam. Diabetes Care. 2002, 25: 1790-1794. 10.2337/diacare.25.10.1790.
Article
PubMed
Google Scholar
Mazzali M, Hughes J, Kim YG, Jefferson A, Kang DH, Gordon KL, Lan HY, Kivlighn S, Johnson RJ: Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension. 2001, 38: 1101-1106. 10.1161/hy1101.092839.
Article
CAS
PubMed
Google Scholar
Feig DI, Nakagawa T, Karumanchi SA, Oliver WJ, Kang DH, Finch J, Johnson RJ: Hypothesis: uric acid, nephron number, and the pathogenesis of essential hypertension. Kidney Int. 2004, 66: 281-287. 10.1111/j.1523-1755.2004.00729.x.
Article
CAS
PubMed
Google Scholar
Dehghan A, van Hoek M, Sijbrands EJG, Hofman A, Witteman JCM: High serum uric acid as a novel risk factor for type 2 diabetes. Diabetes Care. 2008, 31 (2): 361-362.
Article
CAS
PubMed
Google Scholar
Kramer CK, von Muhlen D, Jassal SK, Barrett-Connor E: Serum uric acid levels improve prediction of incident type 2 diabetes in individuals with impaired fasting glucose: the rancho Bernardo study. Diabetes Care. 2009, 32 (7): 1272-1273. 10.2337/dc09-0275.
Article
CAS
PubMed
PubMed Central
Google Scholar
Fang J, Alderman MH: Serum uric acid and cardiovascular mortality: the NHANES I epidemiologic follow-up study, 1971–1992. JAMA. 2000, 283 (18): 2404-2410. 10.1001/jama.283.18.2404.
Article
CAS
PubMed
Google Scholar
Culleton BF, Larson MG, Kannel WB, Levy D: Serum uric acid and risk of cardiovascular disease and mortality: the Framingham heart study. Ann Intern Med. 1999, 31: 7-13.
Article
Google Scholar
Syamala S, Li J, Shankar A: Association between serum uric acid and prehypertension among US adults. J Hypertens. 2007, 25 (8): 1583-1589. 10.1097/HJH.0b013e32813aeb6c.
Article
CAS
PubMed
Google Scholar
Liang J, Xue Y, Zou C, Zhang T, Song H, Qi L: Serum uric acid and prehypertension among Chinese adults. J Hypertens. 2009, 27: 1761-1765. 10.1097/HJH.0b013e32832e0b44.
Article
CAS
PubMed
Google Scholar
Bhole V, Choi JWJ, Kim SW, de Vera M, Choi H: Serum uric acid levels and the risk of type 2 diabetes: a prospective study. Am J Med. 2010, 123 (10): 957-961. 10.1016/j.amjmed.2010.03.027.
Article
CAS
PubMed
PubMed Central
Google Scholar
Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, De Backer G, Ebrahim S, Gjelsvik B, Herrmann-Lingen C, Hoes A, Humphries S, Knapton M, Perk J, Priori SG, Pyorala K, Reiner Z, Ruilope L, Sans-Menendez S, Scholte op Reimer W, Weissberg P, Wood D, Yarnell J, Zamorano JL, Walma E, Fitzgerald T, Cooney MT, Dudina A, European Society of Cardiology (ESC) Committee for Practice Guidelines (CPG): Fourth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Eur Heart J. 2007, 28: 2375-2414.
Article
PubMed
Google Scholar
Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT, Rocellla EJ, National High Blood Pressure Education Program Coordinating Committee: Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003, 42 (6): 1206-1252. 10.1161/01.HYP.0000107251.49515.c2.
Article
CAS
PubMed
Google Scholar
Prediabetes FAQs: American diabetes association. 2012, http://www.diabetes.org/diabetes-basics/prevention/pre-diabetes/pre-diabetes-faqs.html. Accessed Jan. 29.
Google Scholar
Fam AG: Gout, diet, and the insulin resistance syndrome. J Rheumatol. 2002, 29: 1350-1355.
CAS
PubMed
Google Scholar
Ishizaka N, Ishizaka Y, Toda A, Tani M, Koike K, Yamakado M, Nagai R: Changes in waist circumference and body mass indeks in relation to changes in serum uric acid in Japanese individuals. J Rheumatol. 2010, 37: 410-416. 10.3899/jrheum.090736.
Article
CAS
PubMed
Google Scholar
Loachimescu AG, Brennan DM, Hoar BM, Hazen SL, Hoogwerf BJ: Serum uric acid is an independent predictor of all-cause mortality in patients at high risk of cardiovascular disease. Arthritis&Rheumatism. 2008, 58 (2): 623-630. 10.1002/art.23121.
Article
Google Scholar
Baynes JW, Thorpe SR: Role of oxidative stress in diabetic complications a new perspective on an old paradigm. Diabetes. 1999, 48: 1-9. 10.2337/diabetes.48.1.1.
Article
CAS
PubMed
Google Scholar
Masuo K, Kawaguchi H, Mikami H, Ogihara T, Tuck ML: Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation. Hypertension. 2003, 42: 474-480. 10.1161/01.HYP.0000091371.53502.D3.
Article
CAS
PubMed
Google Scholar
Kawamoto R, Tomita H, Oka Y, Ohtsuka N: Relationship between serum uric acid concentration, metabolic syndrome and carotid atherosclerosis. Intern Med. 2006, 45 (9): 605-614. 10.2169/internalmedicine.45.1661.
Article
PubMed
Google Scholar
Nakagawa T, Hu H, Zharikov S, Tuttle KR, Short RA, Glushakova O, Ouyang X, Feig DI, Block ER, Herrera-Acosta J, Patel JM, Johnson RJ: A causal role for uric acid in fructose-induced metabolic syndrome. Am J Physiol. 2006, 290: 625-631.
Google Scholar
Hayden MR, Tyagi SC: Uric acid: a new look at an old risk marker for cardiovascular disease, metabolic syndrome, and type1 diabetes mellitus: the urate redox shuttle. Nutr Metab (Lond). 2004, 19 (1): 10-
Article
Google Scholar
Conen D, Wietlisbach V, Bovet P, Shamlaye C, Riesen W, Paccaud F, Burnier M: Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular factors in a developing country. BMC Publ Health. 2004, 4-9. 10.11861471-2458-4-9.
Google Scholar
Nan H, Qiao Q, Dong Y, Gao W, Tang B, Qian R, Tuomilehto J: The prevalence of hyperuricemia in a population of the coastal city of Qingdao. China. J Rheumatol. 2006, 33: 1346-1350.
PubMed
Google Scholar
Zhu Y, Pandya BJ, Choi HK: Prevalence of gout and hyperuricemia in the US general population: the national health and nutrition examination survey 2007–2008. Arthritis & Rheumatism. 2011, 63: 3136-3141. 10.1002/art.30520.
Article
Google Scholar
Sundström J, Sullivan L, D'Agostino RB, Levy D, Kannel WB, Vasan RS: Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence. Hypertension. 2005, 45: 28-33.
Article
PubMed
Google Scholar
Butler R, Morris AD, Belch JJF, Hill A, Struthers AD: Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension. Hypertension. 2000, 35: 746-751. 10.1161/01.HYP.35.3.746.
Article
CAS
PubMed
Google Scholar